- Retinal Development and Disorders
- Transplantation: Methods and Outcomes
- Retinal Diseases and Treatments
- Surgical Simulation and Training
- Complement system in diseases
- Yersinia bacterium, plague, ectoparasites research
- Corneal surgery and disorders
- Health and Conflict Studies
- Viral Infections and Immunology Research
- Abdominal vascular conditions and treatments
- Zoonotic diseases and public health
- Viral Infections and Outbreaks Research
- Simulation-Based Education in Healthcare
- Global Security and Public Health
- Pleural and Pulmonary Diseases
- CRISPR and Genetic Engineering
- Mechanical Circulatory Support Devices
- Herpesvirus Infections and Treatments
- Corneal Surgery and Treatments
- Mosquito-borne diseases and control
- Foreign Body Medical Cases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Viral-associated cancers and disorders
- Animal Disease Management and Epidemiology
University of Nevada, Reno
2022-2024
Jacksonville College
2024
Mayo Clinic in Florida
2018-2024
WinnMed
2024
Sierra Eye Associates
2023
Regenxbio (United States)
2023
Betsi Cadwaladr University Health Board
2021
Cardiff and Vale University Health Board
2021
University of Washington
2013
Office of International Affairs
2012
Abstract Management of vitreoretinal disorders (e.g., neovascular age-related macular degeneration [nAMD] and diabetic edema [DME]) have assumed the standard therapy lifelong anti-VEGF injections with drugs like aflibercept, brolucizumab, ranibizumab bevacizumab. However, burden imposed on patients is a major deterrent for continual recovery. Faricimab, bispecific antibody, blocking both VEGF-A Ang-2 molecules, produces comparable functional anatomical results, less injections, significantly...
ABSTRACT The complete sequence of retroperitoneal fibromatosis-associated herpesvirus Macaca nemestrina (RFHVMn), the pig-tailed macaque homolog Kaposi's sarcoma-associated (KSHV), was determined by next-generation analysis a sarcoma (KS)-like tumor. Colinearity genes observed with KSHV genome, and core had strong homology to corresponding genes. RFHVMn lacked homologs open reading frame 11 (ORF11) ORFs K5 K6, which appear have been generated duplication K3 K4 after divergence RFHV....
Aziz, Aamir A. BS; Khan, Hannah MPH; Khanani, Zoha A.; Thomas, Mathew J. Huma; Ahmed, Abrahim Gahn, Greggory M. MD; Arshad MD, MA Author Information
Introduction Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) and a leading cause vision loss for which there are currently two FDA-approved treatments (pegcetacoplan avacincaptad pegol). The complement system, major effector arm innate adaptive immunity, has been implicated in the pathogenesis GA. This review aims to provide comprehensive overview mechanisms underlying dysregulation GA current therapeutic strategies treat via targeting system.
Lung volume reduction surgery (LVRS) has historically been performed as a bilateral operation. We aimed to compare the short-term morbidity and mortality between unilateral LVRS.
Introduction/Background: Patients with heart failure and those waiting for a transplant often experience significant decrease in their ability to perform daily activities exercise, leading lower quality of life. Although exercise-based cardiac rehabilitation (EBCR) is possible treatment option, its effectiveness has not been well measured, resulting limited adoption. Research Questions/Hypothesis: Could physical before receiving improve functional status better outcomes? Goals/Aims: Our...
Abstract Introduction Studies that have reviewed technologies including haptic feedback and virtual reality indicate the usefulness of simulation. However, these are not universally available. Less technologically innovative simulation methods utilise learning environment, equipment presentation can still effectively support surgical teaching. A review was undertaken to assess effect lower fidelity on skill acquisition. Method Two courses enrolled 12 14 respectively, with trainees ranging in...